Who Paid My Doc
Ziihera
Drug Hematology/Oncology
NDC 68727-950-02
General payments
$1,079,460
Research payments
$9,766,791
Through program year 2025, $1,079,460 in general payments and $9,766,791 in research payments were reported against Ziihera (Hematology/Oncology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $922,951 | 2,045 |
| 2025 | Research | $9,715,726 | 1,837 |
| 2024 | General | $156,509 | 289 |
| 2024 | Research | $51,065 | 7 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 49 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 49 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
2,334 general · 1,844 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.